ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.857 EUR | +0.31% |
|
-0.38% | +1.71% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 428.2 USD | +1.28% | +6.28% | +5.14% | 8.46% | ||
| 976.2 USD | +0.25% | +1.81% | +11.12% | 7.85% | ||
| 307.8 USD | -0.75% | +2.76% | +6.85% | 7.84% | ||
| 67.22 USD | +1.92% | +2.49% | -17.08% | 7.77% | ||
| 224.8 USD | +1.51% | +1.29% | -13.33% | 3.86% | ||
| 125.7 USD | +7.13% | +2.46% | +25.82% | 3.85% | ||
| 150.8 USD | +0.20% | -0.18% | -21.14% | 2.51% | ||
| 112.9 USD | +2.17% | -5.14% | -18.94% | 2.31% | ||
| 80.56 USD | -0.58% | -1.96% | -16.52% | 1.87% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 5.857 | +0.31% | 3 978 |
| 24-05-10 | 5.839 | -0.34% | 6,577 |
| 24-05-09 | 5.859 | -0.26% | 186 |
| 24-05-08 | 5.874 | -0.44% | 5,721 |
| 24-05-07 | 5.9 | +0.85% | 3,502 |
Other stock markets
Real-time BOERSE MUENCHEN
Last update May 13, 2024 at 02:17 pm
More quotesDescription
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2017-10-17
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-04-29 )
| AuM (EUR) | 421 M€ |
|---|---|
| AuM 1M | 432 M€ |
| AuM 3 months | 408 M€ |
| AuM 6 months | 329 M€ |
| AuM 12 months | 433 M€ |
- Stock Market
- ETF
- 2B70 ETF
